Eugenol Inclusion In Oral Pain Monograph Requires Actual Use Data – FDA
This article was originally published in The Tan Sheet
Executive Summary
Both a clinical safety trial and an actual use study are necessary to support including eugenol in the oral discomfort (relief) products final monograph, FDA tells the Consumer Healthcare Products Association
You may also be interested in...
CHPA Benzocaine Study Protocol Includes Consumer Research Survey
Studying OTC toothache relief ingredient benzocaine in an actual use setting presents "insurmountable hurdles," the Consumer Healthcare Products Association tells FDA in an April 16 briefing document
CHPA Benzocaine Study Protocol Includes Consumer Research Survey
Studying OTC toothache relief ingredient benzocaine in an actual use setting presents "insurmountable hurdles," the Consumer Healthcare Products Association tells FDA in an April 16 briefing document
CHPA Benzocaine Study Protocol Includes Consumer Research Survey
Studying OTC toothache relief ingredient benzocaine in an actual use setting presents "insurmountable hurdles," the Consumer Healthcare Products Association tells FDA in an April 16 briefing document